4.8 Review

Electronic Drugs: Spatial and Temporal Medical Treatment of Human Diseases

期刊

ADVANCED MATERIALS
卷 33, 期 47, 页码 -

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/adma.202005930

关键词

bioresorbable electronics; electronic drugs; implantable devices; ingestible electronics; patch‐ type devices

资金

  1. National Research Foundation of Korea (NRF) - Ministry of Science and ICT [NRF-2017M3A7B4049466]
  2. Priority Research Centers Program through the National Research Foundation of Korea [NRF-2019R1A6A1A11055660]
  3. KIST Institutional Program [2Z06430-20-P064]
  4. National Research Foundation of Korea (NRF) - Korea government (MSIT) [2019R1C1C1006720]
  5. Korea Medical Device Development Fund - Korea government (the Ministry of Science and ICT) [2020M3E5D8103325, KMDF-202012B02-02]
  6. Korea Medical Device Development Fund - Korea government (Ministry of Trade, Industry and Energy) [20013455]
  7. Technology Innovation Program (Center for Super Critical Material Industrial Technology) - Ministry of Trade, Industry & Energy(MOTIE, Korea). [20013621]
  8. National Research Foundation of Korea [2019R1C1C1006720, 2019R1A6A1A11055660, KMDF_PR_20200901_0039-05] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Recent advances in diagnostics and medicines emphasize the importance of spatial and temporal aspects in monitoring and treating diseases. Electronic drugs (e-drugs), as an innovative approach, have been developed to overcome the limitations of conventional therapies and deliver specific treatments to targeted tissues or organs in a more precise spatiotemporal manner.
Recent advances in diagnostics and medicines emphasize the spatial and temporal aspects of monitoring and treating diseases. However, conventional therapeutics, including oral administration and injection, have difficulties meeting these aspects due to physiological and technological limitations, such as long-term implantation and a narrow therapeutic window. As an innovative approach to overcome these limitations, electronic devices known as electronic drugs (e-drugs) have been developed to monitor real-time body signals and deliver specific treatments to targeted tissues or organs. For example, ingestible and patch-type e-drugs could detect changes in biomarkers at the target sites, including the gastrointestinal (GI) tract and the skin, and deliver therapeutics to enhance healing in a spatiotemporal manner. However, medical treatments often require invasive surgical procedures and implantation of medical equipment for either short or long-term use. Therefore, approaches that could minimize implantation-associated side effects, such as inflammation and scar tissue formation, while maintaining high functionality of e-drugs, are highly needed. Herein, the importance of the spatial and temporal aspects of medical treatment is thoroughly reviewed along with how e-drugs use cutting-edge technological innovations to deal with unresolved medical challenges. Furthermore, diverse uses of e-drugs in clinical applications and the future perspectives of e-drugs are discussed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据